IDH1 and glioblastoma: In each tumor type examined, we failed to detect a relationship between 5hmC staining in IDH1 R132H-immunoreactive tumors compared to IDH1 R132H-immunonegative tumors (see Figure 5), including diffuse astrocytoma, anaplastic astrocytomas, and glioblastomas.